Meet the Minds Behind the Innovation

Associate Professor in Neuroendocrinology and Physiology at University of Copenhagen. Kenneth is a leading expert in insect systems biology and molecular physiology, with extensive research published in top-tier journals including PNAS. His groundbreaking work on protein machines forms the scientific foundation of Yngvi Bio's technology platform.

Researcher at Novo Nordisk Foundation Center for Protein Research with deep expertise in protein structure and drug delivery systems. Eva specializes in translating laboratory discoveries into practical applications, focusing on protein stability and formulation science essential for field-deployable solutions.

Co-Founder of Green Alchemy and Member of the Board of Advisors with extensive expertise in regulatory affairs for biosolutions and biotechnology. Claudia brings deep knowledge of global registration strategies, environmental studies, and regulatory compliance essential for bringing innovative agricultural biotechnology to market.

Deep Tech Business Developer with specialized expertise in biotechnology commercialization and startup operations. Icíar bridges the gap between scientific innovation and market reality, developing strategic partnerships and business models that bring cutting-edge research to agricultural markets.

Molecular Biologist and Postdoctoral Researcher at University of Copenhagen specializing in insect physiology and entomology. Muhammad's research focuses on understanding pest behavior and biology, providing crucial insights for developing targeted protein-based control strategies.

Malene is a biotechnologist with a strong foundation in stem cell biology, bioreactor operations, and process optimization. She brings hands-on experience from both academic and industry settings, including Novo Nordisk and Hannover Medical School, where she worked on the cultivation of iPSC-derived immune cells and organoids. At Yngvi Bio, Malene supports our transition from lab-scale protocols to scalable production, contributing essential skills in upscaling, quality control, and bioprocess development. 

Jarne Elleholm is a seasoned venture capital investor and managing partner with over 20 years of experience, having led three Danish-based funds managing more than €110 million across 24 startups. He brings strong operational leadership to the table - previously serving as CEO of Stonehaven Incubate and holding senior roles such as Vice President—alongside a proven exit track record in biotech and animal health, including Aresa’s IPO and successful acquisitions by Abbott, Thermo Fisher, and Zoetis. He is currently Chair of the Board at Yngvi Bio, and also serves as co-founder and Chair of EvodiaBio, a pioneering bio-solutions company in the food and beverage sector, where he continues to drive strategic growth and fundraising efforts.

Shubhecha leads business development and strategic growth at Yngvi Bio, with a particular passion for forging strong industry-startup partnerships. She brings experience in commercialization, venture strategy, and innovation ecosystems, and plays a key role in aligning scientific potential with market needs. Her focus lies in building collaborative bridges that accelerate impact, scale, and sustainability.

Benedicte Flambard brings extensive experience in leading global plant-health and biologicals businesses as Vice President at FMC Corporation - where she spearheaded the expansion of FMCs biologicals portfolio (e.g. acquisition of BioPhero) and launched new sustainable crop protection tools. She has a strong track record in commercial strategy and R&D across biotech and microbial sectors, with leadership roles at Boehringer Ingelheim, Merial, and Chr. Hansen, and serves as Chairperson at Anizome, focused on microbiome therapeutics. As a board member at Yngvi Bio, she contributes her broad AgTech expertise - from scale-up to regulatory and global rollout - to guide our protein-based pest-control innovation at an industrial scale.

Christopher brings a unique combination of legal expertise and entrepreneurial insight, with a strong focus on intellectual property strategy and technology positioning. His background spans both early-stage innovation and deep IP portfolio development, helping startups translate scientific innovation into long-term value. As an external advisor, Christopher supports Yngvi in navigating the intersection of invention, protection, and commercialization.